Curcumin and synbiotics cooled inflammation markers; leptin would not budge

Carrying excess weight is frequently accompanied by chronic low-grade inflammation, a slow simmer of immune activity that contributes to metabolic dysfunction. A large industry sells supplements claimed to cool that simmer, from curcumin to probiotics, yet the comparative effects of these products on inflammatory markers have never been clear. Individual trials tend to test one product against a placebo, which cannot tell a buyer whether green tea extract, zinc or a synbiotic is the better bet. This review set out to rank 14 supplementation strategies against each other on the blood markers of inflammation.

The authors searched five major databases for randomised controlled trials published between January 2000 and January 2026 that tested nutritional supplements in adults with overweight or obesity. Sixty trials qualified. They then ran a network meta-analysis, a technique that pools direct and indirect comparisons so every supplement can be ranked against every other, even when two products were never tested head to head. Outcomes were changes in inflammatory biomarkers, including IL-6, TNF-α and C-reactive protein, plus adiponectin and leptin, and the confidence in each estimate was formally graded.

Effects were marker specific rather than universal. Green tea extract and curcumin significantly reduced IL-6. Synbiotics, curcumin and probiotics combined with omega-3 lowered TNF-α, while probiotics with omega-3, synbiotics, zinc and curcumin all reduced C-reactive protein. Synbiotics also increased adiponectin levels. The clear null was leptin: no supplement significantly reduced it. Exploratory analysis suggested that age, exercise alongside supplementation and the proportion of male participants may partly explain why results varied between trials.

The picture that emerges is not one winner but a set of biomarker-specific effects, which complicates the marketing story that any single anti-inflammatory supplement covers all bases. The findings broadly favour curcumin and the gut-targeted combinations, while leaving open the questions that matter for use: dose, duration and which participants respond. The authors themselves urge cautious interpretation because trials differed on all three, and they call for further high-quality trials before firm conclusions can be drawn about any individual product.

If you are carrying extra weight and curious about supplements for inflammation, this review suggests the candidates with the best pooled evidence for shifting blood markers are curcumin, green tea extract, synbiotics and probiotics paired with omega-3. It equally suggests scepticism about any product promising to lower leptin, since none managed it here. Worth remembering is what this evidence is not: a change in a blood marker is not the same as a demonstrated improvement in health, and the review cannot say which dose or duration produced the effects.